Delek US (DK) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
2024 was a transformational year with major operational improvements, $100 million in cost reductions, and the launch of the Enterprise Optimization Plan targeting $80–$120 million in annual cash flow improvements from H2 2025.
Completed KSR turnaround, advanced midstream deconsolidation, and consistently ran Big Spring refinery over 70,000 bbls/day with no major turnarounds planned for 2025.
Sold retail assets for $390 million, reduced DKL stake from 78.7% to 63.6%, and executed asset swaps and acquisitions, including Gravity and H2O Midstream.
DKL delivered record results, announced 2025 EBITDA guidance of $480–$520 million, and is expanding the Libby Gas Plant with completion expected in H1 2025.
Paid $16 million in dividends and repurchased $42 million in shares, reflecting a balanced capital allocation approach.
Financial highlights
Q4 2024 net loss of $414 million ($6.55/share), including a $212 million goodwill impairment; adjusted net loss was $161 million ($2.54/share); adjusted EBITDA loss of $23 million.
Q4 2024 net revenues were $2.37 billion, down from $3.94 billion in Q4 2023; full-year 2024 net revenues were $11.85 billion.
Logistics segment delivered $107 million in Q4 adjusted EBITDA; full-year adjusted EBITDA was $313.7 million.
Cash flow from operations for Q4 2024 was a use of $164 million; year-end cash balance was $735.6 million; consolidated net debt was $2.03 billion, with net debt excluding DKL at $159.6 million.
Q4 capital expenditures totaled $198 million, with $140 million in refining and the remainder in midstream projects.
Outlook and guidance
No major refinery turnarounds planned for 2025; focus on operational improvements and EOP expected to deliver $80–$120 million in annual cash flow improvement, trending toward the high end.
Q1 2025 operating expenses expected at $220–$235 million; G&A at $55–$60 million; D&A at $100–$105 million; net interest expense at $78–$88 million.
System throughput target for Q1 2025: 278,000–292,000 bbls/day; DKL 2025 EBITDA guidance raised to $480–$520 million.
Standalone capital outlook for 2025 is $150–$170 million.
Latest events from Delek US
- Board recommends voting for all proposals, highlighting governance, compensation, and ESG focus.DK
Proxy Filing10 Mar 2026 - Q4 2025 saw robust EBITDA and cash flow gains, driven by EOP and regulatory relief.DK
Q4 202527 Feb 2026 - Q2 net loss, record throughput, and asset sales to deliver $500M+ cash inflow.DK
Q2 20242 Feb 2026 - Q3 2024: $93M adjusted net loss, $70.6M EBITDA, record Logistics, major asset sales, strong liquidity.DK
Q3 202416 Jan 2026 - Shareholders will vote on directors, executive pay, incentive plan amendment, and auditor ratification.DK
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, incentive plan amendment, and auditor ratification.DK
Proxy Filing1 Dec 2025 - Q2 2025: Net loss, higher adjusted EBITDA, EOP gains, and strong liquidity amid volatility.DK
Q2 202523 Nov 2025 - Q1 2025 net loss of $172.7M, but logistics growth and cash flow initiatives drive outlook.DK
Q1 202521 Nov 2025 - Q3 2025 delivered $434M adjusted net income and $760M EBITDA, fueled by SRE and margin gains.DK
Q3 20259 Nov 2025